Genmab — Juli 2020
-
yes
-
AlphaValue increase target on Genmab to 2213, but keeps reduce rating
-
Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab (“Pom‐PAD‐Dara”) in relapsed/refractory multiple myeloma https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.3209
-
CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2020006200/461232/CD38-deletion-of-human-primary-NK-cells-eliminates?redirectedFrom=fulltext
-
UPDATE 1-BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial - Reuters News
-
I dag er den faldet med halvtredser..;-)
-
ca,
-
Som Solsen skriver tror jeg også kursen har ramt muren på omkring 2200 +/- indtil der kommer nye opdaterede data i løbet af H2.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind